Product Information
CIPROFLOXACIN 0.2% OTIC SOLN is a generic product labeled by Genus Lifesciences Inc., priced at $6.3771 per EA under NDC 64950038114. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Nov 5, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ciprofloxacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/.25mL
Manufacturer
Genus Lifesciences Inc.NDC
64950038114
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
8/19/2026
Active Ingredients
CIPROFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217887FDA Approved
11/5/2024
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3771 per EA |
|---|---|
| All-time high | $7.3838 (Nov 12, 2025) |
| All-time low | $6.3771 (Aug 19, 2026) |
| 52-week high | $7.3838 |
| 52-week low | $6.3771 |
| Median price | $6.9329 |
| Average price | $6.9655 |
| Largest weekly change | +6.2% (Sep 17, 2025) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ciprofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN 0.2% OTIC SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN 0.2% OTIC SOLN, manufactured by Genus Lifesciences Inc., is $6.3771 per EA (NDC 64950038114), effective Aug 19, 2026.
How has the price of CIPROFLOXACIN 0.2% OTIC SOLN changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has declined 6.9%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN 0.2% OTIC SOLN?
Since Aug 13, 2025, the NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has ranged from a low of $6.3771 (Aug 19, 2026) to a high of $7.3838 (Nov 12, 2025), with a median of $6.9329 per EA.
Are there cheaper alternatives to CIPROFLOXACIN 0.2% OTIC SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOXACIN 0.2% OTIC SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN 0.2% OTIC SOLN?
CIPROFLOXACIN 0.2% OTIC SOLN (NDC 64950038114) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.